Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

NEWS: ISS National Lab-Sponsored Research Aims to Improve Cancer Treatments, Muscle Health, and Regenerative Medicine

globenewswire.com

NEWS: ISS National Lab-Sponsored Research Aims to Improve Cancer Treatments, Muscle Health, and Regenerative Medicine Cape Canaveral, FL, Nov. 19, 2026 (GLOBE NEWSWIRE) -- From screening FDA-approved drugs that could treat age-related muscle loss to developing new cancer therapies and advancing bioprinted tissues, researchers are leveraging the unique environment of space to tackle some of medicine's most pressing challenges. These projects, along with dozens more sponsored by the International Space Station (ISS) National Laboratory are set to launch on NASA's Northrop Grumman Commercial Resupply Services 25 (CRS-25) mission, targeted for liftoff at 10:47 a.m. ET on November 29 from Space Launch Complex 40 at Cape Canaveral Space Force Station in Florida.

In the microgravity environment of the space station, scientists can study cell and tissue behavior in ways that are difficult or impossible to replicate on Earth, providing insights that can accelerate medical discoveries and improve patient outcomes. Below highlights some of the biotechnology and regenerative medicine investigations launching on this mission.

As the nation’s only orbiting laboratory, the ISS National Lab continues to support research from the public and private sectors that harnesses the unique characteristics of space to accelerate scientific discovery and improve quality of life. These biomedical investigations launching on NASA’s Northrop Grumman CRS-25 showcase the diverse ways researchers are leveraging this space-based platform to address challenges in medicine, health, and biotechnology.

To learn more about research sponsored by the ISS National Laboratory, visit www.ISSNationalLab.org.

Attachment